We’re turning the sound up on comprehensive biomarker testing. Every person’s cancer is different. Between all of the lung cancer treatment options available, how can you and your treatment team identify the best path for your individual case? Enter: comprehensive biomarker testing.

Comprehensive biomarker testing looks for biological changes in genes or proteins, like EGFR or ALK, that may be associated with your cancer. Learn more from Jennifer King, PhD, our Chief Scientific Officer.

Learn more about comprehensive biomarker testing.